Cargando…
SARS-CoV-2 Vaccination and Solid Organ Transplant Patients: Data Needed to Inform Safety and Efficacy
Autores principales: | Ison, Michael G., Avery, Robin, Blumberg, Emily, Chin-Hong, Peter, Halasa, Natasha, Kaul, Dan, Pergam, Steve, Theodoropoulos, Nicole M., Wolfe, Cameron R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429513/ https://www.ncbi.nlm.nih.gov/pubmed/33724250 http://dx.doi.org/10.1097/TP.0000000000003747 |
Ejemplares similares
-
2706. Effectiveness and Safety of Shingrix Vaccination in Solid Organ Transplant Recipients at a Large Urban Transplant Center
por: Halkett, Megan, et al.
Publicado: (2023) -
920. A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
por: Boutin, Catherine-Audrey, et al.
Publicado: (2023) -
Donor-Derived Infections: Incidence, Prevention, and Management
por: Theodoropoulos, Nicole, et al.
Publicado: (2016) -
Impact of COVID-19 in solid organ transplant recipients
por: Danziger-Isakov, Lara, et al.
Publicado: (2021) -
SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?
por: Krueger, Karen M., et al.
Publicado: (2022)